A serum mesothelin level is a prognostic indicator for patients with malignant mesothelioma in routine clinical practice

BACKGROUND: Malignant mesothelioma (MM) carries a poor prognosis and response rates to palliative chemotherapy remain low. Identifying patients with MM that are unlikely to respond to chemotherapy could prevent futile treatments and improve patient quality of life. Studies have suggested that solubl...

Descripción completa

Detalles Bibliográficos
Autores principales: Linch, Mark, Gennatas, Spyridon, Kazikin, Stanislav, Iqbal, Jhangir, Gunapala, Ranga, Priest, Kathryn, Severn, Joanne, Norton, Alison, Ayite, Bee, Bhosle, Jaishree, O’Brien, Mary, Popat, Sanjay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4182776/
https://www.ncbi.nlm.nih.gov/pubmed/25227779
http://dx.doi.org/10.1186/1471-2407-14-674

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4182776/
https://www.ncbi.nlm.nih.gov/pubmed/25227779
http://dx.doi.org/10.1186/1471-2407-14-674

Ejemplares similares